![]() |
Volumn 134, Issue 2, 2009, Pages 280-281
|
The impact of ezetimibe and high-dose of statin treatment on LDL levels in patients with heterozygous familial hypercholesterolemia
|
Author keywords
Ezetimibe; Heterozygous familial hypercholesterolemia; Statins
|
Indexed keywords
APOLIPOPROTEIN B;
ATORVASTATIN;
EZETIMIBE;
FLUINDOSTATIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PRAVASTATIN;
ROSUVASTATIN;
SIMVASTATIN;
TRIACYLGLYCEROL;
ADULT;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
FAMILIAL HYPERCHOLESTEROLEMIA;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
TRIACYLGLYCEROL BLOOD LEVEL;
ADULT;
ANTICHOLESTEREMIC AGENTS;
AZETIDINES;
CHOLESTEROL, LDL;
DRUG THERAPY, COMBINATION;
FEMALE;
HETEROZYGOTE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
MALE;
MIDDLE AGED;
|
EID: 64849097241
PISSN: 01675273
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ijcard.2007.12.065 Document Type: Article |
Times cited : (13)
|
References (5)
|